Ignite Creation Date:
2025-12-24 @ 5:28 PM
Ignite Modification Date:
2026-02-25 @ 9:50 PM
Study NCT ID:
NCT03611868
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-08-07
First Post:
2018-07-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors
Sponsor:
Ascentage Pharma Group Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Unresectable or Metastatic Melanoma or Advanced Solid Tumors | View |
| None | Melanoma | View |
| None | Uveal Melanoma | View |
| None | P53 Mutation | View |
| None | MDM2 Gene Mutation | View |
| None | Cutaneous Melanoma | View |
| None | Mucosal Melanoma | View |
| None | Malignant Peripheral Nerve Sheath Tumors (MPNST) | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Metastatic melanoma, MPNST and Advanced Solid Tumors | View |